1st Dental Laboratories PLC
23 January 2008


                          1st Dental Laboratories plc
                 ("1st Dental" or "the Company" or "the Group")

                     PRELIMINARY RESULTS MEET EXPECTATIONS

1st Dental Laboratories plc (AIM: FDT), the UK's leading and only quoted
provider of dental laboratory products to the dental profession, announces its
preliminary results for the year ended 30 November 2007.

For further information:
Andrew Garner, 1st Dental Laboratories plc: 01509 605111
Nicola Marrin, Seymour Pierce: 020 7107 8000

Chairman's Statement

For the year to 30 November 2007, I'm pleased to be able to report significant
performance increases for the Group after a difficult 2005 and 2006 and with the
backdrop of difficult trading conditions at the start of the year 2007. All
efforts during the year have been concentrated very hard on improving
efficiencies, getting the best from our asset base and working with the
resources the Group has at its disposal. This has resulted in a very real
increase in gross margin, net margin and cash generation. The effort made
demonstrates a clear turnaround situation from a year ago which is a credit to
all management and staff involved.

Overview of the results are as follows:

   • Recurring* EBITDA of £1,029k being achieved on turnover of £11,022k
     (2006: £12,085k EBITDA of £682k)
   • Gross margin (excluding exceptional costs) increase of 2.0% to 37.9%
   • Administration costs before e-teeth set up costs reduced by £520k to
     £3,830k
   • Recurring normalised profit** doubled for the second year running to
     £615k (2006: £303k, 2005: £156k). Normalised profit for the Group including
     e-teeth is £396k (2006: £647k loss) representing an increase of £1,043k
   • Net debt reduction in the period of £759k to £1,190k. We took advantage
     of our cash position by making an additional repayment to the bank of 
     £376k. Total repayments made in the year are £808k
   • Net cash inflow from operating activities increased to £1,103k (2006:
     £616k) Net cash inflow before financing was £759k (2006: £160k outflow)

*  recurring is defined as profit from the core laboratory business
** normalised profit is defined as profit before amortisation, share based
   payments and tax

The disruption that was experienced with our NHS client base from April 2006
with the changes in the primary care trust contracts does eventually seem to
have concluded and now good solid order flows are being experienced. This is
very encouraging news.

We have also established national contracts with some of the major dentist
corporate groups for domestic supply which show much promise for organic growth
through our existing asset base.

We have also started to see the benefit of our new venture e-teeth, providing an
on-line purchasing facility at competitive prices for dentists on selected
product lines. Sales have grown at a pace with increases in sales over the last
4 months to our year end of 43%, 57%, 29% and 24% respectively. While these
sales numbers are still relatively small they have overtaken that of our
smallest laboratory. We can report further progress in achieving e-teeth sales
to major corporate dentist groups and many independent practices. It would
appear that presently, none of this discounted business has cannibalised our
existing domestic sales. The Group's performance being reported includes the
absorption of costs totalling £222k for the setting up and running costs of
e-teeth.

We are also seeing good cash generation and an opportunity to reduce our net
debt further in 2008 from the progress made in 2007 which equates to a 41%
decrease in net debt in 2 years.

We can see very real and solid progress during 2007 and see no reason why this
cannot continue throughout 2008. Our market place especially seems to have
settled during the second half of 2007 with a great deal of activity and
progress being made by the dental corporate groups which is having a direct
positive impact on the laboratory market.

Through the commitment and hard work of all the management and staff, the
progress made in 2007 stands as a sound foundation for further improvement in
2008. This gives the Group the opportunity to benefit from further domestic
organic growth, growth from our e-teeth export business, along with the
potential of further acquisition possibilities in due course.


AW Garner
Executive Chairman
23 January 2008

Financial Review

This year has been all about using the improved controls and systems that were
introduced in my first year of office to improve the efficiency of the business.
The work done in 2006 has put the Group in a much better position with regards
to accurate management information which has resulted in no exceptional charge
in the year (2006: £1,450k) and allowed us to report results 31 working days
after year end, which halves the reporting timetable seen 2 years ago (2005
results were announced 63 working days after year end).

During the second quarter of this year the Group launched an online facility for
selected product lines at a competitive price, with production being carried out
in China. This new initiative is called e-teeth.

Sales

Sales decreased by 8.8% to £11,022k, due largely to the drop-off in work
following the changes to dentists' contracts last year. Sales from the new
online facility are encouraging with sales over the last 4 months averaging a
growth rate of 38% on prior month. We are now working very closely with the UK's
most progressive dentistry operator to roll out e-teeth across their 140
practice estate.

Margins

Despite losing over £1 million of sales, recurring* gross margin has increased
2.2% to 38.1%. Improved reporting and a focus on KPIs has allowed the Board to
see more clearly where costs could be reduced and so optimise the efficiency of
operations. E-teeth has been set up to operate at a lower margin than the
domestic laboratories resulting in gross margin for the Group of 37.9%, an
improvement of 3.8% on absolute numbers.

A fully integrated purchase ordering system has been installed during the year,
achieving our objective of consolidating suppliers to reduce administration and
also to increase volume discounts.

Administrative costs

FRS 20 the standard on share based payments has been adopted this year which has
resulted in a charge in the year of £15k and a restatement of prior year numbers
increasing administrative costs by £71k.

Before share options and e-teeth administration and set up costs, administrative
costs have reduced by £464k to £3,815k, representing a 10% saving. Employment
costs at laboratories and centrally account for £85k of the reduction, while
restructuring at board level accounts for £79k of the saving. The Newbury lease
was reassigned in May reducing yearly rental costs by £28k. The remainder of the
savings arose from realigning service providers and operating a tighter control
on costs generally.

E-teeth administration and set up costs were £222k in the year. These costs
included three full time sales people on the road and related advertising costs.

Interest

Interest expense of £174k represents a saving of £25k on the prior year.

Normalised profit (profit before amortisation, share based payments and tax)
Laboratory profit after interest but before amortisation, share based payments,
exceptional costs and tax, has for the second consecutive year doubled to £615k
(2006: £303k, 2005: £156k). This is an encouraging increase and is a direct
result of the financial review completed last year resulting in better control
of costs across the business.

Normalised profit for the Group including e-teeth was £396k (2006: £647k loss)
representing an increase of £1,043k.

After amortisation and share based payments the Group made a loss of £44k (2006:
£212k loss before exceptional and £1,662k after exceptional).

Dividends and shareholder returns

Basic earnings per share before exceptional items during the year showed a
negative figure of 0.11p (2006: 0.50p negative) per share. The directors do not
recommend the payment of a dividend.

Cash

At the year end the Group had a net debt balance of £1,190k a £759k improvement
on the beginning of the year. We took advantage of our cash position and made an
additional repayment to the bank of £376k in the first quarter of the year.

Net cash inflow from operating activities was £1,103k (2006: £616k). The
centralisation of credit control last year continued to produce cash benefits
with a £384k reduction in debtors over the year. Debtor days at the year end
were 44 compared to 54 at prior year end and 62 days in August 06 before credit
control was centralised.

There was an outflow of £174k relating to interest and £147k relating to fixed
asset expenditure. This was a considerable capital expenditure reduction
compared with the prior year of £312k, as we continued to scrutinise all
expenditure in the business. Corporation tax refunds of £52k were received
during the year relating to overpayments for the year ending 30 November 2004.

The final earn-out payment of £75k relating to the acquisition of Riley Dental
Laboratory in Ripley was paid during the year.

Net inflow of cash before financing was £759k (2006: £160k outflow) which is
considered a satisfactory performance in light of the operating performance.

Transition to International Financial Reporting Standards (IFRS)
As an AIM listed company we will adopt IFRS for our Interim Statements for the
period ending 31st May 2008.



Emma Towers
Chief Operating Officer
23 January 2008

Consolidated profit and loss account
for the year ended 30th November 2007

                                                Restated               Restated
                              Notes     2007        2006          2006     2006
                                       £'000       £'000         £'000    £'000
                                       Total   Recurring   Exceptional    Total

Turnover                              11,022      12,085             -   12,085

Cost of sales                         (6,840)     (7,748)         (218)  (7,966)
                                      --------    --------     --------- -------
Gross profit/(loss)                    4,182       4,337          (218)   4,119
                                        37.9%       35.9%                 34.1%
--------------------------     ------ --------    --------     --------- -------
Administrative expenses
before                                (3,627)     (3,906)         (732)   4,638)
goodwill
amortisation
Goodwill amortisation                   (425)       (444)         (500)    (944)
--------------------------     ------ --------    --------     --------- -------

Total administrative expenses         (4,052)     (4,350)       (1,232)  (5,582)
--------------------------     ------ --------    --------     --------- -------
Operating profit/(loss)
before                                   555         431          (950)    (519)
goodwill amortisation
Goodwill amortisation                   (425)       (444)         (500)    (944)
--------------------------     ------ --------    --------     --------- -------
                                      --------    --------     --------- -------
Operating profit/(loss)                  130         (13)       (1,450)  (1,463)

Interest receivable and
similar                                   53          64             -       64
income
Interest payable and similar
charges                                 (227)       (263)            -     (263)
                                      --------    --------     --------- -------
Loss on ordinary activities
before                                   (44)       (212)       (1,450)  (1,662)
taxation

Taxation on ordinary                       -           -             -        -
activities
                                      --------    --------     --------- -------
Loss for the financial year              (44)       (212)       (1,450)  (1,662)
                                      --------    --------     --------- -------

Basic and diluted loss per
ordinary share                    2    (0.11)p     (0.50)p       (3.45)p (3.95)p

There were no recognised gains or losses in either the current or preceding
financial year other than the loss for the financial year as shown above.
All results are derived from continuing operations.


Group and Company balance sheets
at 30th November 2007
                                      Group                     Company
                                2007          2006          2007          2006
                               £'000         £'000         £'000         £'000
Fixed assets
Intangible assets              6,662         7,087         1,119         1,189
Tangible assets                1,832         1,953           831           880
Investments                        -             -         6,428         6,426
                              --------      --------      --------      --------
                               8,494         9,040         8,378         8,495
                              --------      --------      --------      --------

Current assets
Stocks                           321           336             -             -
Debtors                        1,553         1,973         3,846         4,161
Cash at bank and in hand       1,067         1,176             1           307
                              --------      --------      --------      --------
                               2,941         3,485         3,847         4,468

Creditors-amounts falling
due within one year           (1,510)       (2,067)         (610)       (1,091)
                              --------      --------      --------      --------
Net current assets             1,431         1,418         3,237         3,377
                              --------      --------      --------      --------

Total assets less current
liabilities                    9,925        10,458        11,615        11,872
Creditors-amounts falling
due after more than one
year                          (1,625)       (2,129)       (1,611)       (2,097)
                              --------      --------      --------      --------
Net assets                     8,300         8,329        10,004         9,775
                              --------      --------      --------      --------

Capital and reserves
Called up share capital        4,202         4,202         4,202         4,202
Share premium account          6,358         6,358         6,358         6,358
Equity reserve                     -             -            25            23
Profit and loss account       (2,260)       (2,231)         (581)         (808)
                              --------      --------      --------      --------
Equity shareholders' funds     8,300         8,329        10,004         9,775
                              --------      --------      --------      --------


Consolidated cash flow statement
for the year ended 30th November 2007

                                                                2007      2006
                                                               £'000     £'000

Net cash inflow from operating activities                      1,103       616

Returns on investments and servicing of finance                 (174)     (199)

Taxation                                                          52       (40)

Capital expenditure                                             (147)     (312)

Acquisitions and disposals                                       (75)     (225)
                                                             ---------  --------
Cash inflow/(outflow) before financing                           759      (160)

Financing                                                       (868)     (530)
                                                             ---------  --------
Decrease in cash in the year                                    (109)     (690)
                                                             ---------  --------

Reconciliation of net cash flow to movement in net debt

Decrease in cash in the year                                    (109)     (690)
Cash outflow from decrease in debt and lease financing           808       434
Cash outflow on repayment of HP and lease financing               60        90
                                                             ---------  --------
Movement in net debt in the year                                 759      (166)

Opening net debt                                              (1,949)   (1,783)
                                                             ---------  --------
Closing net debt                                              (1,190)   (1,949)
                                                             ---------  --------


Notes

1   Accounting Policies

    Basis of accounting
    The following accounting policies have been applied consistently in dealing 
    with items which are considered material in relation to the Group's 
    financial statements except as noted. These financial statements include the
    first time adoption of FRS 20 Share based payments.

    Basis of preparation
    The financial statements have been prepared in accordance with applicable
    accounting standards and under the historical cost accounting rules.

    Basis of consolidation
    The consolidated financial statements include the financial statements of 
    the company and its subsidiary undertakings made up to 30 November 2007. The
    acquisition method of accounting has been adopted. Under this method, the 
    results of subsidiary undertakings acquired or disposed of in the year are 
    included in the consolidated profit and loss account from the date of 
    acquisition or up to the date of disposal.
    Under section 230(4) of the Companies Act 1985 the company is exempt from 
    the requirement to present its own profit and loss account.

2   Loss per share

    The calculations of loss per share are based on the following losses and 
    number of shares:
                                                                      Restated
                                                        Basic and    Basic and
                                                          diluted      diluted
                                                             2007         2006
    On recurring items:                                     £'000        £'000
    loss per share                                          (0.11)p      (0.50)p
    loss for the financial year                               (44)        (212)

    On exceptional items:
    loss per share                                              -        (3.45)p
    loss for the financial year                                 -       (1,450)

    Total:
    loss per share                                          (0.11)p      (3.95)p
    loss for the financial year                               (44)      (1,662)

    Weighted average number of shares:                       2007         2006
                                                           No. of       No. of
                                                           shares       shares
                                                                         
    No of shares                                       42,017,444   42,017,444

3   Copies of the Group's report and accounts will be available from 1st Dental
    Laboratories plc's registered office at 112, Wetherby Road, Harrogate. HG2 
    7AB on 11 February 2008.


                      This information is provided by RNS
            The company news service from the London Stock Exchange

• News Channel